Financial Daily from THE HINDU group of publications
Wednesday, September 14, 2005
|
Financial Daily from THE HINDU group of publications Wednesday, September 14, 2005 |
|
|
|
|
|
News Update as at 17.00 hrs (IST)
Corporate NEW DELHI: Ranbaxy Laboratories has received US Food and Drug Authority (US FDA) approval for Benazepril Hydrochloride abd Hydroclorothiazide, a high blood pressure drug. The company has received the approval for various dosage forms from five mg to 25 mg, as per the information available with the US FDA site. Ranbaxy had got tentative approval for the drug in 2004. The company had yesterday announced the setting up of its subsidiary in Italy to gain further foothold in the European market. - PTI
Prev: Cummins to set up new manufacturing facility for Rs 15 cr Business Line | NUS Index | |
In Focus BHEL Disinvestment The Yuan Revaluation Dabhol power regenerated Tracking the rains Sethusamudram Canal Project India Inc's overseas acquisition
In Depth Gender Justice Simple Economics Tax Talk
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line
|